Equities

Qyuns Therapeutics Co Ltd

Qyuns Therapeutics Co Ltd

Actions
  • Price (HKD)27.60
  • Today's Change-0.300 / -1.08%
  • Shares traded104.80k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 08:57 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments377614620
Total Receivables, Net114.048.65
Total Inventory3.7700
Prepaid expenses231618
Other current assets, total4.241.490.72
Total current assets418636648
Property, plant & equipment, net363389406
Goodwill, net------
Intangibles, net2.353.050.38
Long term investments------
Note receivable - long term116.7910
Other long term assets0.160.362.73
Total assets7961,0351,067
LIABILITIES
Accounts payable731913
Accrued expenses472923
Notes payable/short-term debt000
Current portion long-term debt/capital leases1216216
Other current liabilities, total111219
Total current liabilities25212270
Total long term debt225233274
Total debt346295290
Deferred income tax0.410.490.56
Minority interest6.192034
Other liabilities, total171819
Total liabilities501393397
SHAREHOLDERS EQUITY
Common stock210181166
Additional paid-in capital830830616
Retained earnings (accumulated deficit)(745)(369)(112)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity295642670
Total liabilities & shareholders' equity7961,0351,067
Total common shares outstanding222222222
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.